Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer

Author： Onagawa T   Shibahara H     Machida S   Hirano Y   Hirashima C   Takamizawa S   Suzuki M  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.18, Iss.6, 2004-06, pp. : 335-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A preliminary study on reduced dose (33 or 25 μg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization–embryo transfer

By Ku Seung-Yup   Choi Young   Jee Byung   Suh Chang   Choi Young   Kim Jung   Moon Shin   Kim Seok  

Gynecological Endocrinology, Vol. 21, Iss. 4, 2005-10 ,pp. : 227-231

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization–embryo transfer

By Doldi Nicola   Persico Paola   Di Sebastiano Francesca   Marsiglio Elena   Ferrari Augusto  

Gynecological Endocrinology, Vol. 22, Iss. 5, 2006-05 ,pp. : 235-238

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology: Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitizafion on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme

By Yamashita Takanori   Ishimaru Tadayuki   Fujishita Akira   Kawano Masahiro   Yamabe Tooru  

Human Reproduction, Vol. 11, Iss. 8, 1996-08 ,pp. : 1615-1619

Oxford University Press

Access to resources Recommend Favorite

Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles

By Yilmaz H   Ozgur K   Isikoglu M   Sonmez C   Uner M  

Gynecological Endocrinology, Vol. 19, Iss. 1, 2004-07 ,pp. : 40-46

Informa Healthcare

Access to resources Recommend Favorite

A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle stimulating hormone concentrations on day 3

By Olivennes F.   Righini C.   Fanchin R.   Torrisi C.   Hazout A.   Glissant M.   Fernandez H.   Frydman R.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1169-1172

Oxford University Press

Access to resources Recommend Favorite